Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction von BRENER, S. J, BARR, L. A, MOSES, J. W, MOLITERNO, D. J, EFFRON, M. B, TOPOL, E. J, BURCHENAL, J. E. B, KATZ, S, GEORGE, B. S, JONES, A. A, COHEN, E. D, GAINEY, P. C, WHITE, H. J, CHEEK, H. B

Volltext

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease von Jones, W. Schuyler, Mulder, Hillary, Wruck, Lisa M, Pencina, Michael J, Kripalani, Sunil, Muñoz, Daniel, Crenshaw, David L, Effron, Mark B, Re, Richard N, Gupta, Kamal, Anderson, R. David, Pepine, Carl J, Handberg, Eileen M, Manning, Brittney R, Jain, Sandeep K, Girotra, Saket, Riley, Danielle, DeWalt, Darren A, Whittle, Jeff, Goldberg, Ythan H, Roger, Veronique L, Hess, Rachel, Benziger, Catherine P, Farrehi, Peter, Zhou, Li, Ford, Daniel E, Haynes, Kevin, VanWormer, Jeffrey J, Knowlton, Kirk U, Kraschnewski, Jennifer L, Polonsky, Tamar S, Fintel, Dan J, Ahmad, Faraz S, McClay, James C, Campbell, James R, Bell, Douglas S, Fonarow, Gregg C, Bradley, Steven M, Paranjape, Anuradha, Roe, Matthew T, Robertson, Holly R, Curtis, Lesley H, Sharlow, Amber G, Berdan, Lisa G, Hammill, Bradley G, Harris, Debra F, Qualls, Laura G, Marquis-Gravel, Guillaume, Modrow, Madelaine F, Marcus, Gregory M, Carton, Thomas W, Nauman, Elizabeth, Waitman, Lemuel R, Kho, Abel N, Shenkman, Elizabeth A, McTigue, Kathleen M, Kaushal, Rainu, Masoudi, Frederick A, Antman, Elliott M, Davidson, Desiree R, Edgley, Kevin, Merritt, James G, Brown, Linda S, Zemon, Doris N, McCormick, Thomas E, Alikhaani, Jacqueline D, Gregoire, Kenneth C, Rothman, Russell L, Harrington, Robert A, Hernandez, Adrian F

Volltext

Effects of abciximab, ticlopidine, and combined abciximab/ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty von FREDRICKSON, B. J, TURNER, N. A, KLEIMAN, N. S, GRAZIADEI, N, MARESH, K, MASCELLI, M. A, EFFRON, M. B, MCINTIRE, L. V

Volltext

Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: The controlled abciximab and device investigation to lower late angioplasty complication... von TCHENG, James E, KANDZARI, David E, FAHY, Martin, LANSKY, Alexandra J, MEHRAN, Roxana, STONE, Gregg W, GRINES, Cindy L, COX, David A, EFFRON, Mark B, GARCIA, Eulogio, GRIFFIN, John J, GUAGLIUMI, Giulio, STUCKEY, Thomas, TURCO, Mark

Volltext

Abciximab readministration: Results of the reopro readministration registry von TCHENG, James E, KEREIAKES, Dean J, DAMARAJU, Lakshmi, SCHANTZ, Allen, EFFRON, Mark B, BRADEN, Gregory A, LINCOFF, A. Michael, GEORGE, Barry S, KLEIMAN, Neal S, SANE, David C, CINES, Douglas B, JORDAN, Robert E, MASCELLI, Mary Ann, LANGRALL, Mary Ann

Volltext

Facilitated PCI in Patients with ST-Elevation Myocardial Infarction von Ellis, Stephen G, Tendera, Michal, de Belder, Mark A, van Boven, Ad J, Widimsky, Petr, Janssens, Luc, Andersen, H.R, Betriu, Amadeo, Savonitto, Stefano, Adamus, Jerzy, Peruga, Jan Z, Kosmider, Maciej, Katz, Olivier, Neunteufl, Thomas, Jorgova, Julia, Dorobantu, Maria, Grinfeld, Liliana, Armstrong, Paul, Brodie, Bruce R, Herrmann, Howard C, Montalescot, Gilles, Neumann, Franz-Josef, Effron, Mark B, Barnathan, Elliot S, Topol, Eric J

Volltext

A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet T... von ANGIOLILLO, Dominick J, BADIMON, Juan Jose, SAUCEDO, Jorge F, FRELINGER, Andrew L, MICHELSON, Alan D, JAKUBOWSKI, Joseph A, BAOJIN ZHU, OJEH, Clement K, BAKER, Brian A, EFFRON, Mark B

Volltext

Readministration of abciximab: Interim report of the ReoPro Readministration Registry von Tcheng, James E., Kereiakes, Dean J., Braden, Gregory A., Jordan, Robert E., Mascelli, Mary Ann, Langrall, Mary Ann, Effron, Mark B.

Volltext

Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: Ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventions von Kleiman, Neal S., Grazeiadei, Nikki, Maresh, Kelly, Taylor, Rebecca J., Frederick, Bart, Lance, Ellen T., Effron, Mark B., Jordan, Robert E., Mascelli, Mary A.

Volltext

Platelet glycoprotein IIb/IIIa receptor antagonists and their use in elderly patients von MAK, K.-H, EFFRON, M. B, MOLITERNO, D. J

Volltext

Changes in Myosin Isoenzymes, ATPase Activity, and Contraction Duration in Rat Cardiac Muscle With Aging Can Be Modulated by Thyroxine von Effron, Mark B, Bhatnagar, Gopal M, Spurgeon, Harold A, Ruaño-Arroyo, Gualberto, Lakatta, Edward G

Volltext

Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm von Shapiro, Edward P., Effron, Mark B., Lima, Sandra, Ouyang, Pamela, Siu, Cynthia O., Bush, David

Volltext

Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: Insights from the switching anti-platelet (SWAP) study von Saucedo, Jorge F., Angiolillo, Dominick J., DeRaad, Roger, Frelinger, Andrew L., Gurbel, Paul A., Costigan, Timothy M., Jakubowski, Joseph A., Ojeh, Clement K., Duvvuru, Suman, Effron, Mark B.

Volltext

A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data von Kennedy, John S., Bymaster, Frank P., Schuh, Leslie, Calligaro, David O., Nomikos, George, Felder, Christian C., Bernauer, Mark, Kinon, Bruce J., Baker, Robert W., Hay, Donald, Roth, H. John, Dossenbach, Martin, Kaiser, Christopher, Beasley, Charles M., Holcombe, John H., Effron, Mark B., Breier, Alan

Volltext

Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways von Braun, Oscar Ö., Angiolillo, Dominick J., Ferreiro, Jose L., Jakubowski, Joseph A., Winters, Kenneth J., Effron, Mark B., Duvvuru, Suman, Costigan, Timothy M., Sundseth, Scott S., Walker, Joseph R., Saucedo, Jorge F., Kleiman, Neal S., Varenhorst, Christoph

Volltext

Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients: High on-treatment platelet reactivity analysis of the TRIPLET trial von DIODATI, Jean G, SAUCEDO, Jorge F, FISHER, Harold N, ANGIOLILLO, Dominick J, CARDILLO, Tracy E, JAKUBOWSKI, Joseph A, HENNEGES, Carsten, EFFRON, Mark B, LIPKIN, Fred R, WALKER, Joseph R, DUVVURU, Suman, SUNDSETH, Scott S

Volltext

Effect of abciximab on the pattern of reperfusion in patients with acute myocardial infarction treated with primary angioplasty von Brener, Sorin J, Barr, Lawrence A, Burchenal, J.E.B, Wolski, Katherine E, Effron, Mark B, Topol, Eric J

Volltext

Effects of diltiazem or propranolol during exercise training of hypertensive men von Stewart, K J, Effron, M B, Valenti, S A, Kelemen, M H

Volltext

Contemporary use of platelet function and pharmacogenomic testing among acute myocardial infarction patients treated with PCI in the United States: insights from the TRANSLATE-ACS... von Wang, T. Y., Henry, T. D., Mccoy, L. A., Berger, P. B., Cohen, D. J., Effron, M. B., Zettler, M., Vaitkus, P. T., Messenger, J. C., Peterson, E. D.

Volltext

Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways von O. Ö. Braun, D. J. Angiolillo, J. L. Ferreiro, J. A. Jakubowski, K. J. Winters, M. B. Effron, S. Duvvuru, T. M. Costigan, S. Sundseth, J. R. Walker, J. F. Saucedo, N. S. Kleiman, C. Varenhorst

Volltext